Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO3 pseudogene 44 is a *human pseudogene* that is related by sequence to the mitochondrial gene encoding cytochrome c oxidase subunit III (MT-CO3 or COX3)[3]. Unlike the functional MT-CO3 gene, which codes for a protein critical to mitochondrial respiratory chain complex IV[1][2], MTCO3P44 does **not produce a functional protein**, is categorized as a "pseudogene," and is not known to perform any biological function or participate in disease or drug responses[3]. There is no evidence to support its consideration as a therapeutic target, biomarker, or functional gene product. Key points: - MTCO3P44 is a *pseudogene*, not an active gene or protein target[3]. - It is not a receptor, enzyme, transporter, or transcription factor. - It does not play a biological role, participate in disease processes, or interact with drugs. - There is nothing in current scientific literature indicating use for therapeutic targeting, biomarker, or safety concern. Error/Incorrectness: MTCO3P44 should not be confused with the functional mitochondrial gene MT-CO3 (cytochrome c oxidase subunit III), which has roles in disease and cellular respiration[1][2]. As a pseudogene, MTCO3P44 is not a drug target, nor is it implicated in cell signaling, mitochondrial dysfunction, or any listed disease. If used as a target, this would be incorrect. The only appropriate classification for its molecular category is "Other (Pseudogene)"[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO3 pseudogene 44 (MTCO3P44).